Links between Thyroid Disorders and Glucose Homeostasis
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Thyroid disorders and diabetes mellitus often coexist and are closely related. Several studies have shown a higher prevalence of thyroid disorders in patients with diabetes mellitus and vice versa. Thyroid hormone affects glucose homeostasis by impacting pancreatic β-cell development and glucose metabolism through several organs such as the liver, gastrointestinal tract, pancreas, adipose tissue, skeletal muscles, and the central nervous system. The present review discusses the effect of thyroid hormone on glucose homeostasis. We also review the relationship between thyroid disease and diabetes mellitus: type 1, type 2, and gestational diabetes, as well as guidelines for screening thyroid function with each disorder. Finally, we provide an overview of the effects of antidiabetic drugs on thyroid hormone and thyroid disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279 · cited 2×
“A higher prevalence of thyroid disorders is seen in patients with type 1 diabetes mellitus (T1DM) [1] and type 2 diabetes mellitus (T2DM) compared to the general population [2,3].”
BackgroundStagnaro-Green, A., Abalovich, M., Alexander, E., Azizi, F., Mestman, J., Negro, R., Nixon, A., Pearce, E. N., Soldin, O. P., Sullivan, S., et al. (2011) · Thyroid · doi:10.1089/thy.2011.0087 · Cited by 2,942
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
Yki-Järvinen, H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041001 · Cited by 1,830
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567 · cited 8×
“There is no mention of monitoring thyroid function in T2DM in the 2015 NICE guidelines [58], the ADA guideline [59], the ATA/AACE guideline [60], and the ISPAD guideline (Table 2) [61,62].”
BackgroundMethodInfluentialMetformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985 · cited 1×
“org hormone and neuropeptides released from the brain, pancreas, liver, intestine, adipose, and muscle tissue [8].”
BackgroundSubclinical hypothyroidism and pregnancy outcomes
Casey, B. M., Dashe, J. S., Wells, C. E., McIntire, D. D., Byrd, W., Leveno, K. J., & Cunningham, F. G. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000152345.99421.22 · Cited by 903
Gestational diabetes mellitus: mechanisms, treatment, and complications
Johns, E. C., Denison, F. C., Norman, J. E., & Reynolds, R. M. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.09.004 · Cited by 828 · cited 1×
“Thyroid dysfunction and DM are the common endocrinopathies during pregnancy and can affect both maternal and fetal health [71,72].”
BackgroundBaskin, H. J., Cobin, R. H., Duick, D. S., Gharib, H., Guttler, R. B., Kaplan, M. M., Segal, R. L., Garber, J. R., Hamilton Jr, C. R., Handelsman, Y., et al. (2002) · Endocrine Practice · doi:10.4158/1934-2403-8.6.457 · Cited by 673
Bjerre Knudsen, L., Madsen, L. W., Andersen, S., Almholt, K., de Boer, A. S., Drucker, D. J., Gotfredsen, C., Egerod, F. L., Hegelund, A. C., Jacobsen, H., et al. (2010) · Endocrinology · doi:10.1210/en.2009-1272 · Cited by 672 · cited 2×
“Long-term dosing with liraglutide causes C-cell hyperplasia, calcitonin production in a dose dependent manner, and tumor formation in rodents [121-123].”
BackgroundAntenatal Thyroid Screening and Childhood Cognitive Function
Lazarus, J. H., Bestwick, J. P., Channon, S., Paradice, R., Maina, A., Rees, R., Chiusano, E., John, R., Guaraldo, V., George, L. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106104 · Cited by 635 · cited 1×
“not been shown to cause improved pregnancy outcome and neurocognitive function in offspring [89,90].”
BackgroundThyroid Function Is Associated with Components of the Metabolic Syndrome in Euthyroid Subjects
Roos, A., Bakker, S. J. L., Links, T. P., Gans, R. O. B., & Wolffenbuttel, B. H. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1718 · Cited by 542
Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy
Casey, B. M., Thom, E. A., Peaceman, A. M., Varner, M. W., Sorokin, Y., Hirtz, D. G., Reddy, U. M., Wapner, R. J., Thorp, J. M., Saade, G., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606205 · Cited by 462 · cited 1×
“not been shown to cause improved pregnancy outcome and neurocognitive function in offspring [89,90].”
BackgroundThyroid disease in pregnancy: new insights in diagnosis and clinical management
Korevaar, T. I. M., Medici, M., Visser, T. J., & Peeters, R. P. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.93 · Cited by 441
Subclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis
Han, C., He, X., Xia, X., Li, Y., Shi, X., Shan, Z., & Teng, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135233 · Cited by 258 · cited 1×
“93-fold in T2DM patients compared to non-diabetics and that subclinical hypothyroidism may also be associated with an increase in diabetic complications [56].”
BackgroundThe interface between thyroid and diabetes mellitus
Duntas, L. H., Orgiazzi, J., & Brabant, G. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04029.x · Cited by 247
Thyroid Dysfunction in Patients With Type 1 Diabetes
Umpierrez, G. E., Latif, K. A., Murphy, M. B., Lambeth, H. C., Stentz, F., Bush, A., & Kitabchi, A. E. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1181 · Cited by 215
Glucose counterregulation: prevention and correction of hypoglycemia in humans
Cryer, P. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e149 · Cited by 198 · cited 1×
“Counterregulatory hormones that act to prevent hypoglycemia include: glucagon, epinephrine, GH, cortisol, and neurotransmitters [142].”
BackgroundChen, G., Xu, S., Renko, K., & Derwahl, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1754 · Cited by 196
Hegedüs, L., Moses, A. C., Zdravkovic, M., Le Thi, T., & Daniels, G. H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2318 · Cited by 194 · cited 2×
“This may be due to C-cells in monkeys and humans having lower expression of GLP-1R and decreased responsiveness to GLP-1R agonists compared to rodents [125].”
BackgroundHormonal mechanisms of recovery from insulin-induced hypoglycemia in man.
Gerich, J., Davis, J., Lorenzi, M., Rizza, R., Bohannon, N., Karam, J., Lewis, S., Kaplan, R., Schultz, T., & Cryer, P. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.4.e380 · Cited by 183 · cited 1×
“When plasma glucose level falls below the normal level, glucagon secretion rises, leading to hepatic glucose production and return of plasma glucose to normal range [9].”
BackgroundScreening for Thyroid Dysfunction: U.S. Preventive Services Task Force Recommendation Statement
LeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-0483 · Cited by 176
Thyrotropin Suppression by Metformin
Vigersky, R. A., Filmore-Nassar, A., & Glass, A. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1210 · Cited by 174 · cited 2×
“It was first reported that metformin therapy decreases serum TSH levels in patients with T2DM with primary hypothyroidism in 2006 [96].”
BackgroundTSH-Lowering Effect of Metformin in Type 2 Diabetic Patients
Cappelli, C., Rotondi, M., Pirola, I., Agosti, B., Gandossi, E., Valentini, U., De Martino, E., Cimino, A., Chiovato, L., Agabiti-Rosei, E., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0273 · Cited by 173 · cited 3×
“Several studies have shown that metformin administration in diabetic patients with primary hypothyroidism is associated with a reduction in serum TSH levels and this effect was observed in both patients under TH replacement therapy and in untreated patients [97,98].”
BackgroundExcess thyroid hormone and carbohydrate metabolism
Potenza, M., Via, M. A., & Yanagisawa, R. T. (2009) · Endocrine Practice · doi:10.4158/ep.15.3.254 · Cited by 155 · cited 1×
“org tate diabetic ketoacidosis not only in patients with T1DM, but also in patients with T2DM when accompanied by insulin deficiency which can enhance the risk for lipolysis [16,45,46].”
BackgroundMorbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066711 · Cited by 142 · cited 2×
“In addition, a higher prevalence of DM is noted in patients with thyroid disorders [4-6].”
BackgroundColesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence
Fonseca, V. A., Handelsman, Y., & Staels, B. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01181.x · Cited by 130 · cited 1×
“FDA to improve glycemic control in adults T2DM patients [135].”
BackgroundEffects of treatment with metformin on TSH levels: a meta-analysis of literature studies
Lupoli, R., Di Minno, A., Tortora, A., Ambrosino, P., Arianna Lupoli, G., & Di Minno, M. N. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2965 · Cited by 102 · cited 1×
“The TSH-lowering effect of metformin was observed in patients with overt hypothyroidism and subclinical hypothyroidism, but not in euthyroid patients [98,99].”
BackgroundThvilum, M., Brandt, F., Almind, D., Christensen, K., Brix, T. H., & Hegedüs, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075789 · Cited by 92 · cited 2×
“In addition, a higher prevalence of DM is noted in patients with thyroid disorders [4-6].”
BackgroundA longitudinal study of thyroid markers across pregnancy and the risk of gestational diabetes
Rawal, S., Tsai, M. Y., Hinkle, S. N., Zhu, Y., Bao, W., Lin, Y., Panuganti, P., Albert, P. S., Ma, R. C. W., & Zhang, C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02442 · Cited by 92 · cited 1×
“Recently, there is a report that higher free T3 levels in early pregnancy may correlate with a greater risk for GDM developing compared to women who have normal levels of this hormone [84].”
BackgroundLamari, Y., Boissard, C., Moukhtar, M. S., Jullienne, A., Rosselin, G., & Garel, J.-M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00895-2 · Cited by 73
Hegedüs, L., Sherman, S. I., Tuttle, R. M., von Scholten, B. J., Rasmussen, S., Karsbøl, J. D., Daniels, G. H., & for the LEADER Publication Committee on behalf of the LEADER Trial Investigators (2018) · Diabetes Care · doi:10.2337/dc17-1956 · Cited by 67 · cited 1×
“Similarly, in the Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER) Trial, liraglutide did not increase calcitonin or cause C-cell malignancies [127].”
Crespel, A., De Boisvilliers, F., Gros, L., & Kervran, A. (1996) · Endocrinology · doi:10.1210/endo.137.9.8756532 · Cited by 67
Thyroid hormone T3 counteracts STZ induced diabetes in mouse
Verga Falzacappa, C., Mangialardo, C., Madaro, L., Ranieri, D., Lupoi, L., Stigliano, A., Torrisi, M. R., Bouchè, M., Toscano, V., & Misiti, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019839 · Cited by 52
Metadata
- Authors
- Eom, Y. S., Wilson, J. R., & Bernet, V. J.
- Venue
- Diabetes & Metabolism Journal
- Publisher
- Korean Diabetes Association
- Published
- 2022-03-31
- Volume
- 46
- Issue
- 2
- Pages
- 239-256
- ISSN
- 2233-6079 (ISSN-L)
- 2233-6087
- OpenAlex
- W4220977430
- Cited by
- 162
- References
- 37
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.